18Nov 2022
Prognosis and the Effect of De-Escalation of Antiplatelet Therapy After Nuisance Bleeding in Patients With Myocardial Infarction

Prognosis and the Effect of De-Escalation of Antiplatelet Therapy After Nuisance Bleeding in Patients With Myocardial Infarction

The purpose was to examine the prognostic significance of NB in patients receiving potent dual antiplatelet treatment (DAPT) after acute myocardial infarction and the impact of de-escalation of DAPT on clinical outcomes thereafter. NB occurred in 416 patients (16.7%) after 1 month of ticagrelor-based DAPT. At 1 year, NB was not associated with increased BARC 2, 3, or 5 bleeding and major adverse cardiovascular events. However, patients with NB had an increased risk of BARC 2, 3, or 5 bleeding at 6 months, which diminished over the next 6 months. NB was frequent in patients with acute myocardial infarction on 1-month ticagrelor-based DAPT and was associated with an early increase in bleeding. DAPT de-escalation after NB may reduce bleeding without increasing ischemic events.

  • #cardiology

Like

Save

Share